0001209191-22-043290.txt : 20220727 0001209191-22-043290.hdr.sgml : 20220727 20220727182244 ACCESSION NUMBER: 0001209191-22-043290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220725 FILED AS OF DATE: 20220727 DATE AS OF CHANGE: 20220727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Al-Wakeel Yasir B. CENTRAL INDEX KEY: 0001650691 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39592 FILM NUMBER: 221112228 MAIL ADDRESS: STREET 1: MERRIMACK PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQUARE, SUITE B7201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kronos Bio, Inc. CENTRAL INDEX KEY: 0001741830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 212-871-7920 MAIL ADDRESS: STREET 1: 1300 S. EL CAMINO REAL STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-25 0 0001741830 Kronos Bio, Inc. KRON 0001650691 Al-Wakeel Yasir B. C/O KRONOS BIO, INC. 1300 SO. EL CAMINO REAL, SUITE 300 SAN MATEO CA 94402 0 1 0 0 Chief Financial Officer Common Stock 2022-07-25 4 A 0 53600 0.00 A 216841 D Employee Stock Option (Right to Buy) 5.02 2022-07-25 4 A 0 40000 0.00 A 2032-07-24 Common Stock 40000 40000 D 50% of the shares subject to the stock option shall vest and become exercisable on June 30, 2023 and the remaining shares shall vest and become exercisable on December 31, 2023. /s/ Allison Frisbee, Attorney-in-Fact 2022-07-27